Intervju med Syncro Groups VD Claes Persson

Comment

2024-04-05

Comment on Pharma Equity Group’s Positive Final Results From the Phase II Trial of the Drug Candidate RNX-051

Equity research report

2024-03-27

Movinn Q4-23

Comment

2024-03-22

Comment on Movinn’s Annual Report

Equity research report

2024-03-22

Pharma Equity Group Q4-23

Comment

2023-12-14

Comment on STENOCARE Expanding in Australia